Moreover, high neoantigen expression was associated with decreased mortality risk in the whole study samples, T-cell exhaustion subgroup, and PR positive subgroup, suggesting that neoantigens can serve as potential immunogenic agents to improve patient survival in breast cancer. This evidence concerns the gene PGR and breast carcinoma.